LGND
Ligand Pharma (LGND)
NASDAQ
$306.97-$0.86 (-0.28%)
Price as of Oct 22, 2026 7:50 PM EDT
  • $6.3B
    Market Cap
  • 69.63%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
TUDOR INVESTMENT CORP ET AL
79.00%
15.8M
+15.8M (+100.00%)
Sep 30, 2025
BLACKROCK, INC.
15.56%
3.1M
+139,073 (+4.48%)
Jun 30, 2026
BLACKROCK FUNDING, INC. /DE
14.78%
2.9M
-53,548 (-1.82%)
Dec 31, 2024
BLACKROCK INC.
14.40%
2.9M
+3,226 (+0.11%)
Jun 30, 2024
VANGUARD GROUP INC
10.40%
2.1M
-2,391 (-0.12%)
Dec 31, 2025
BLACKROCK FUND ADVISORS
8.89%
1.8M
+187,911 (+10.60%)
Dec 31, 2016
INVESCO LTD.
6.03%
1.2M
+378,040 (+31.46%)
Jun 30, 2026

Current Ownership Distribution

  • Institutions357.6M (52.35%)
  • Mutual Funds321.2M (47.02%)
  • Insiders4.3M (0.63%)
  • Other0 (0.00%)

Insider Transactions

  • 0.63% (4.3M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 9
    Number of InsiderSelling (last 12 months)
  • $869.4M
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Reardon Andrew
CLO & Secretary
Exempt
Oct 02, 2026
$0.00
340
$0.00
29,104
Reardon Andrew
CLO & Secretary
Exempt
Oct 02, 2026
$17,771.80
340
$52.27
36,854
Reardon Andrew
CLO & Secretary
Sell
Oct 02, 2026
$251,991.41
833
$302.51
36,021
Reardon Andrew
CLO & Secretary
Sell
Oct 02, 2026
$599,803.73
1,976
$303.54
34,045
Reardon Andrew
CLO & Secretary
Sell
Oct 02, 2026
$467,431.14
1,535
$304.52
32,510
Reardon Andrew
CLO & Secretary
Sell
Oct 02, 2026
$123,698.09
404
$306.18
32,106
Reardon Andrew
CLO & Secretary
Sell
Oct 02, 2026
$72,189.91
235
$307.19
31,871
Reardon Andrew
CLO & Secretary
Sell
Oct 02, 2026
$5,231.58
17
$307.74
31,854
Zimmermann Martine
Sell
Sep 10, 2026
$342,000.00
1,200
$285.00
3,897
Reardon Andrew
CLO & Secretary
Sell
Sep 03, 2026
$85,195.62
300
$283.99
41,214
Reardon Andrew
CLO & Secretary
Sell
Sep 03, 2026
$513,300.78
1,800
$285.17
39,414
Reardon Andrew
CLO & Secretary
Sell
Sep 03, 2026
$605,649.07
2,115
$286.36
37,299
Reardon Andrew
CLO & Secretary
Sell
Sep 03, 2026
$110,697.24
385
$287.53
36,914
Reardon Andrew
CLO & Secretary
Sell
Sep 03, 2026
$115,591.68
400
$288.98
36,514
Haas Jason
Exempt
Aug 12, 2026
$0.00
6,138
$0.00
0
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$0.00
2,869
$0.00
0
Haas Jason
Exempt
Aug 12, 2026
$316,475.28
6,138
$51.56
11,119
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$0.00
7,171
$0.00
0
Haas Jason
Sell
Aug 12, 2026
$2.1M
7,138
$292.81
3,981
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$0.00
16,179
$0.00
0
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$0.00
3,348
$0.00
0
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$0.00
2,074
$0.00
0
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$854,898.36
16,179
$52.84
43,875
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$145,262.96
2,074
$70.04
45,949
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$159,946.75
2,869
$55.75
48,818
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$410,324.62
7,171
$57.22
55,989
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$230,141.52
3,348
$68.74
59,337
Espinoza Octavio
Chief Financial Officer
Sell
Aug 12, 2026
$9.2M
31,641
$292.06
27,696
Reardon Andrew
CLO & Secretary
Exempt
Aug 03, 2026
$0.00
5,000
$0.00
29,444
Reardon Andrew
CLO & Secretary
Exempt
Aug 03, 2026
$261,350.00
5,000
$52.27
46,514